Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement

Autor: Dangas, George D., Tijssen, Jan G. P., Wöhrle, Jochen, Søndergaard, Lars, Gilard, Martine, Möllmann, Helge, Makkar, Raj R., Herrmann, Howard C., Giustino, Gennaro, Baldus, Stephan, de Backer, Ole, Guimarães, Ana H. C., Gullestad, Lars, Kini, Annapoorna, von Lewinski, Dirk, Mack, Michael, Moreno, Raúl, Schäfer, Ulrich, Seeger, Julia, Tchétché, Didier, Thomitzek, Karen, Valgimigli, Marco, Vranckx, Pascal, Welsh, Robert C., Wildgoose, Peter, Volkl, Albert A., Zazula, Ana, van Amsterdam, Ronald G. M., Mehran, Roxana, Windecker, Stephan, Dangas, G. D., Windecker, S., Mehran, R., Tijssen, J. G. P., Welsh, R. C., Vranckx, P., Valgimigli, M., van Amsterdam, R. G. M., Thomitzek, K., Wildgoose, P., Colombo, A., Prendergast, B., Makkar, R., Mack, M., Webb, J., Marx, Steven O., Corvaja, Nicola, Ghodsi, Newsha, DiStefano, Douglas, Kaufman, David

Publikováno v: Dangas, George D; Tijssen, Jan G P; Wöhrle, Jochen; Søndergaard, Lars; Gilard, Martine; Möllmann, Helge; Makkar, Raj R; Herrmann, Howard C; Giustino, Gennaro; Baldus, Stephan; De Backer, Ole; Guimarães, Ana H C; Gullestad, Lars; Kini, Annapoorna; von Lewinski, Dirk; Mack, Michael; Moreno, Raúl; Schäfer, Ulrich; Seeger, Julia; Tchétché, Didier; ... (2020). A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. The New England journal of medicine, 382(2), pp. 120-129. Massachusetts Medical Society 10.1056/NEJMoa1911425
Article
Dipòsit Digital de la UB
Universidad de Barcelona
New England journal of medicine, 382(2), 120-129. Massachussetts Medical Society
Dangas, G D, Tijssen, J G P, Wöhrle, J, Søndergaard, L, Gilard, M, Möllmann, H, Makkar, R R, Herrmann, H C, Giustino, G, Baldus, S, De Backer, O, Guimarães, A H C, Gullestad, L, Kini, A, von Lewinski, D, Mack, M, Moreno, R, Schäfer, U, Seeger, J, Tchétché, D, Thomitzek, K, Valgimigli, M, Vranckx, P, Welsh, R C, Wildgoose, P, Volkl, A A, Zazula, A, van Amsterdam, R G M, Mehran, R, Windecker, S & GALILEO Investigators 2020, ' A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement ', The New England Journal of Medicine, vol. 382, no. 2, pp. 120-129 . https://doi.org/10.1056/NEJMoa1911425
Dangas, G D, Tijssen, J G P, Wöhrle, J, Søndergaard, L, Gilard, M, Möllmann, H, Makkar, R R, Herrmann, H C, Giustino, G, Baldus, S, de Backer, O, Guimarães, A H C, Gullestad, L, Kini, A, von Lewinski, D, Mack, M, Moreno, R, Schäfer, U, Seeger, J, Tchétché, D, Thomitzek, K, Valgimigli, M, Vranckx, P, Welsh, R C, Wildgoose, P, Volkl, A A, Zazula, A, van Amsterdam, R G M, Mehran, R, Windecker, S & GALILEO Investigators 2020, ' A controlled trial of rivaroxaban after transcatheter aortic-valve replacement ', New England Journal of Medicine, vol. 382, no. 2, pp. 120-129 . https://doi.org/10.1056/NEJMoa1911425

Background Whether the direct factor Xa inhibitor rivaroxaban can prevent thromboembolic events after transcatheter aortic-valve replacement (TAVR) is unclear. Methods We randomly assigned 1644 patients without an established indication for oral anti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90c3ae5ab6f694fae00da8d0f58ce2f3

Transfemoral TAVR in Nonagenarians: From the CENTER Collaboration

Autor: Vlastra, W., Chandrasekhar, J., Vendrik, J., Gutierrez-Ibanes, E., Tchetche, D., de Brito, F. S., Barbanti, M., Kornowski, R., Latib, A., D'Onofrio, A., Ribichini, F., Baan, J., Tijssen, J. G. P., Pan, M., Dumonteil, N., Mangione, J. A., Sartori, S., D'Errigo, P., Tarantini, G., Lunardi, M., Orvin, K., Pagnesi, M., Sanchez Gila, J., Modine, T., Dangas, G., Mehran, R., Piek, J. J., Delewi, R.

Publikováno v: JACC: Cardiovascular Interventions, 12(10), 911-920. Elsevier Inc.
JACC. Cardiovascular interventions, 12(10), 911-920. Elsevier Inc.

Objectives: This study aimed to compare differences in patient characteristics and clinical outcomes of nonagenarians undergoing transcatheter aortic valve replacement (TAVR) versus patients younger than 90 years of age and to test the predictive acc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1f82539f31c645b7d7a269b456d7172f
https://research.vumc.nl/en/publications/f22eb285-f17a-4ae3-99ed-24d6649c5c44

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

One-Year Clinical Outcomes of Patients Presenting With ST-Segment Elevation Myocardial Infarction Caused by Bifurcation Culprit Lesions Treated With the Stentys Self-Apposing Coronary Stent: Results From the APPOSITION III Study

Autor: Grundeken, M. J., Lu, H., Vos, N., Ijsselmuiden, A., Geuns, R. -J, Wessely, R., Dengler, T., La Manna, A., Silvain, J., Montalescot, G., Spaargaren, R., Tijssen, J. G. P., Winter, R. J., Joanna Wykrzykowska, Amoroso, G., Koch, K. T.

Publikováno v: Journal of invasive cardiology, 29(8), 253-258. HMP Communications
Journal of Invasive Cardiology, 29(8), 253-258. HMP Communications
Scopus-Elsevier
Journal of Invasive Cardiology, 29, 8, pp. 253-258
Journal of Invasive Cardiology, 29, 253-258

Item does not contain fulltext OBJECTIVE: To investigate outcomes in patients with ST-segment elevation myocardial infarction (STEMI) after treatment with the Stentys self-apposing stent (Stentys SAS; Stentys S.A.) for bifurcation culprit lesions. BA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1626be3d9d3d18060d31f43f9226b062
https://pure.amc.nl/en/publications/oneyear-clinical-outcomes-of-patients-presenting-with-stsegment-elevation-myocardial-infarction-caused-by-bifurcation-culprit-lesions-treated-with-the-stentys-selfapposing-coronary-stent-results-from-the-apposition-iii-study(6bf8c016-26e5-40bb-9c28-81ce97af7e38).html